Skip to main content

Table 3 PR of screening non-participation by the selected CDGs ≤2 years and >2–10 years before screening (n = 144,264)

From: Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study

 

Unadjusted

Model 1a

Model 2b

 

≤2 years

>2–10 years

≤2 years

>2–10 years

≤2 years

>2–10 years

 

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

PR (95 % CI)

Cardiovascular diseases

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.24 (1.16–1.31)

1.16 (1.11–1.21)

1.13 (1.06–1.21)

1.04 (0.99–1.09)

1.05 (0.99–1.13)

0.98 (0.93–1.02)

Cancer

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.63 (1.54–1.74)

1.19 (1.11–1.27)

1.56 (1.46–1.66)

1.16 (1.08–1.24)

1.50 (1.40–1.60)

1.10 (1.03–1.17)

Hypertension

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.00 (0.91–1.09)

0.99 (0.93–1.06)

0.97 (0.87–1.07)

0.97 (0.91–1.04)

0.92 (0.83–1.02)

0.93 (0.87–0.99)

Chronic mental illness

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.93 (1.82–2.04)

1.78 (1.71–1.86)

1.62 (1.53–1.71)

1.51 (1.44–1.57)

1.51 (1.42–1.60)

1.40 (1.35–1.46)

Diabetes

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.27 (1.19–1.36)

1.41 (1.33–1.50)

1.14 (1.06–1.22)

1.23 (1.17–1.31)

1.05 (0.97–1.13)

1.10 (1.04–1.17)

Chronic obstructive pulmonary disease

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.87 (1.75–1.99)

1.68 (1.59–1.78)

1.62 (1.52–1.73)

1.43 (1.35–1.52)

1.51 (1.42–1.62)

1.32 (1.24–1.40)

Chronic neurological disorders

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.50 (1.35–1.65)

1.57 (1.44–1.71)

1.36 (1.23–1.50)

1.40 (1.29–1.52)

1.24 (1.12–1.37)

1.23 (1.13–1.34)

Chronic arthritis

      

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.02 (0.90–1.15)

1.04 (0.94–1.16)

0.97 (0.86–1.10)

0.99 (0.89–1.11)

0.90 (0.80–1.02)

0.89 (0.80–1.00)

Chronic bowel disease

    

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

0.80 (0.68–0.94)

0.79 (0.69–0.90)

0.81 (0.69–0.94)

0.78 (0.68–0.89)

0.75 (0.65–0.88)

0.71 (0.61–0.81)

Chronic liver disease

     

 No

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

1.40 (1.17–1.67)

1.47 (1.26–1.72)

1.20 (1.00–1.43)

1.24 (1.06–1.43)

1.12 (0.93–1.34)

1.08 (0.92–1.26)

Chronic kidney disease

    

 No

1 (ref)

(ref)

1 (ref)

1 (ref)

1 (ref)

1 (ref)

 Yes

2.22 (1.94–2.55)

1.83 (1.57–2.14)

1.93 (1.69–2.20)

1.61 (1.36–1.90)

1.70 (1.49–1.94)

1.40 (1.19–1.65)

  1. aAdjusted for age, ethnicity, marital status and education
  2. bAdjusted for age, ethnicity, marital status, education, for being registered in the NPR or PCRR with the other studied chronic diseases, and for being registered in the NPR or PCRR with one of the CDGs in the other time period (yes/no). E.g. cancer 0–2 year before screening is adjusted for SEP, for the remaining 10 studied diseases and for being in hospital contact with one of the 11 included chronic disease groups >2–10 years before screening
  3. Statistically significant results in bold